Adobe Systems Incorporated (ADBE) Earnings: An Early Look

Adobe Systems Incorporated (NASDAQ:ADBE)Earnings season is winding down, with most companies already having reported their quarterly results. But there are still some companies left to report, and Adobe Systems Incorporated (NASDAQ:ADBE) is about to release its quarterly earnings. The key to making smart investment decisions with stocks releasing their quarterly reports is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.

Software giant Adobe Systems Incorporated (NASDAQ:ADBE) is best known for its PDF-reader and photo-editing software, but the company has a much broader reach across the creative-design, publishing, and online analytics segments. Let’s take an early look at what’s been happening with Adobe Systems Incorporated (NASDAQ:ADBE) over the past quarter and what we’re likely to see in its quarterly report on Tuesday.

Stats on Adobe

Analyst EPS Estimate $0.31
Change From Year-Ago EPS (46%)
Revenue Estimate $986 million
Change From Year-Ago Revenue (5.7%)
Earnings Beats in Past 4 Quarters 2

Source: Yahoo! Finance.

Will Adobe paint a prettier picture this quarter?
Analysts have had some concerns about Adobe’s prospects in recent months, cutting their earnings estimates for the just-ended quarter by $0.02 per share and slashing nearly a dime from full fiscal-year 2013 consensus earnings. But the stock hasn’t responded badly to those fears, rising 10% since mid-December.

Among consumers, Adobe’s Acrobat PDF-reader and Photoshop image software represent the company’s most visible products. Yet among investors, Adobe Systems Incorporated (NASDAQ:ADBE) is arguably best known for the battle it had with Apple Inc. (NASDAQ:AAPL) over its Flash software, as Apple infamously said it would never include Flash in any of its mobile devices. In response, Adobe shifted to the more widely accepted HTML5, showing the influence that the iDevice maker had in the mobile space.

Adobe has had difficulty bouncing back both from that battle and the broader economic recession. Although Adobe Systems Incorporated (NASDAQ:ADBE) has grown its revenue, profits still lag behind where they were in 2008. Moreover, last quarter, it gave disappointing guidance for 2013, pointing to expected revenue and profit declines for the fiscal year. Right now, analysts expect a 40% drop in earnings per share this year, with only a muted bounce in fiscal 2014.

Looking forward, the company is trying to join the trend toward cloud computing with its “Creative Cloud” initiative, whereby Adobe will offer monthly subscription packages rather than pricey software licenses. Yet as better-established cloud rivals salesforce.com, inc. (NYSE:CRM) and International Business Machines Corp. (NYSE:IBM) build out their offerings, they’re likely to come up with products, either on their own or through partnerships with smaller companies, that will compete directly with Adobe’s offerings.

In its quarterly report, watch for Adobe to give a status update on its efforts to become a bigger player in the cloud-computing industry. For better or worse, Adobe Systems Incorporated (NASDAQ:ADBE) appears committed to the strategy, and the short-term impact on earnings could lead to more rewarding long-term success if the company can figure out how to beat its new rivals.

The article Adobe Earnings: An Early Look originally appeared on Fool.com and is written by Dan Caplinger.

Fool contributor Dan Caplinger owns shares of Apple. You can follow him on Twitter: @DanCaplinger. The Motley Fool recommends Adobe Systems, Apple, and salesforce.com and owns shares of Apple and IBM.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!